Rhythm Pharmaceuticals In...

NASDAQ: RYTM · Real-Time Price · USD
96.83
0.35 (0.36%)
At close: Aug 15, 2025, 1:04 PM

Rhythm Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-260.6M -184.68M -181.12M -69.61M
Depreciation & Amortization
1.56M 1.76M 1.67M 1.16M
Stock-Based Compensation
39.68M 32.55M 19.83M 20.8M
Other Working Capital
2.42M 4.38M -13.26M -15.15M
Other Non-Cash Items
94.9M 9.4M 5.91M -250K
Deferred Income Tax
n/a n/a n/a -100M
Change in Working Capital
10.57M 4.81M -19.72M 1.9M
Operating Cash Flow
-113.88M -136.16M -173.43M -146M
Capital Expenditures
n/a -47K -4.28M -5.43M
Cash Acquisitions
n/a n/a 4M 100M
Purchase of Investments
-268.31M -354.92M -251.94M -524.97M
Sales Maturities Of Investments
260.64M 354.97M 284.25M 361.25M
Other Investing Acitivies
-40.5M -5.67M -4M 7M
Investing Cash Flow
-48.17M -5.67M 28.03M -62.16M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 25.49M 82.72M 4.75M
Financial Cash Flow
191.24M 74.37M 213.83M 166.48M
Net Cash Flow
29.19M -67.6M 68.43M -41.68M
Free Cash Flow
-113.88M -136.2M -177.71M -151.44M